Viking Therapeutics, Inc. Archives - PeptideBlog

Viking Therapeutics, Inc.

Viking Therapeutics, Inc.

4 registered trials on this site, 2 active. This page lists the trials this organization is registered as lead sponsor of, for the compounds covered on PeptideBlog.net. It is a registry listing, not an assessment of the company or its products.

Compounds covered

Registered trials

TrialCompoundPhaseStatusSponsorEnrolledPrimary completionRegistry updated
Oral VK2735 for Weight Management Phase 3 (SUNRISE 1)
NCT07868835
VK2735Phase 3RecruitingViking Therapeutics, Inc.560Jul 2028Nov 16, 2026
Oral VK2735 for Weight Management in Adults With Type 2 Diabetes Mellitus Phase 3 (SUNRISE 2)
NCT07868939
VK2735Phase 3RecruitingViking Therapeutics, Inc.560Oct 2028Nov 16, 2026
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
NCT07104383
VK2735Phase 3Active not recruitingViking Therapeutics, Inc.1,100Jul 1, 2027Apr 7, 2026
VK2735 for Weight Management Phase 3
NCT07104500
VK2735Phase 3Active not recruitingViking Therapeutics, Inc.4,500Jul 1, 2027Nov 24, 2025

Data: ClinicalTrials.gov, U.S. National Library of Medicine. See the full trial tracker.